NeuroSigma

Neuro Sigma

Medical Devices, Wilshire BLVD, Los Angeles, , 90024, California, 10960, United States, 1-10 Employees

neurosigma.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: +13*********

Who is NEUROSIGMA

NeuroSigma, Inc. is a Los Angeles-based bioelectronics company commercializing external trigeminal nerve stimulation (eTNS) technology. NeuroSigma's Monarch eTNS System is a bioelectronic...

Read More

map
  • 10960 Wilshire BLVD, Los Angeles, California, 90024, United States Headquarters: 10960 Wilshire BLVD, Los Angeles, California, 90024, United States
  • 2008 Date Founded: 2008
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Medical Devices

SIC SIC Code: 3845 | NAICS Code: 334510 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from NEUROSIGMA

NeuroSigma Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding NeuroSigma

Answer: NeuroSigma's headquarters are located at Wilshire BLVD, Los Angeles, , 90024, California, 10960, United States

Answer: NeuroSigma's phone number is +13*********

Answer: NeuroSigma's official website is https://neurosigma.com

Answer: NeuroSigma's revenue is $1 Million to $5 Million

Answer: NeuroSigma's SIC: 3845

Answer: NeuroSigma's NAICS: 334510

Answer: NeuroSigma has 1-10 employees

Answer: NeuroSigma is in Medical Devices

Answer: NeuroSigma contact info: Phone number: +13********* Website: https://neurosigma.com

Answer: NeuroSigma, Inc. is a Los Angeles-based bioelectronics company commercializing external trigeminal nerve stimulation (eTNS) technology. NeuroSigma's Monarch eTNS System is a bioelectronic medical device that uses external trigeminal nerve stimulation to treat neurological and neuropsychiatric disorders. In 2019, the Monarch eTNS System became the first-ever medical device cleared by FDA for treating pediatric ADHD. The new Monarch Pediatric Care Co-Pay Program is making eTNS therapy available to a substantially greater number of children diagnosed with ADHD.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access